Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM66883
Volume:
10 |
8 |
Aug 2026
Pages:
1-10
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
PhD ,School of Management
CMR University, Lakeside Campus, Bangalore, India
PhD, School of Management
CMR University, Lakeside Campus, Bangalore, India
PhD, School of Management
CMR University, Lakeside Campus, Bangalore, India
School of Management
CMR University, Lakeside Campus, Bangalore, India
School of Management
CMR University, Lakeside Campus, Bangalore, India
This paper scrutinises the allegation that coronavirus disease 2019 (COVID-19) was a biological weapon used by China to devastate or eliminate older generations considered economically unproductive. Rather than presuming the allegation true, the study disaggregates it into four testable propositions: laboratory engineering, deliberate release, demographic selectivity and state intent. It applies an evidence-triangulation framework to peer-reviewed genomic and epidemiological research, the World Health Organization’s 2025 independent assessment, declassified intelligence assessments, Chinese mortality and vaccination data, demographic economics, and international biosecurity law. The analysis finds that the origin of SARS-CoV-2 is not conclusively resolved. Zoonotic spillover is supported by the spatial concentration of early cases around the Huanan market, two early viral lineages, and wildlife-associated genetic material in virus-positive market samples; a research-related accident cannot be excluded because laboratory records, sequence databases, occupational-health data and other primary evidence remain unavailable. Yet neither pathway proves weaponisation. No verified evidence establishes deliberate release, age-specific engineering, an operational delivery plan, or an official policy to kill older citizens. The age gradient in COVID-19 mortality is biologically expected across countries and reflects immunosenescence, comorbidity and frailty rather than nationality-specific targeting. Moreover, China’s prolonged and economically costly suppression strategy, free vaccination programme, later elderly-vaccination campaigns, retirement-age reform and silver-economy policy are inconsistent with the alleged objective, even though the abrupt 2022 reopening and inadequate protection of the oldest people constituted serious governance failures. The paper concludes that the bioweapon–demographic attrition hypothesis is unsupported on the presently available record. It recommends continued investigation, radical data transparency, stronger biosafety governance and careful separation of legitimate origin inquiry from claims of intentional demographic extermination.
KEYWORDS
On the evidence available through August 2026, the proposition that COVID-19 was a Chinese biological weapon designed or used to wipe out older generations is not supported. The origin of SARS-CoV-2 remains unresolved: zoonotic spillover currently has the more coherent scientific evidence base, while a research-related accident remains a legitimate hypothesis requiring further data. Neither scenario establishes deliberate release. The virus shows no verified age-targeting mechanism; its mortality gradient follows globally observed biological vulnerability. No authenticated operational, documentary or intelligence evidence demonstrates an age-eradication policy. The economic motive is also poorly founded. Older people contribute through formal work, care, savings, consumption, knowledge and family support, while an uncontrolled pandemic imposes economy-wide losses. China’s costly zero-COVID programme, vaccination efforts, retirement-age reform and silver-economy strategy contradict the proposed objective, even as failures in elderly vaccination, reopening and transparency demand criticism. The responsible verdict is therefore: origin uncertain; laboratory accident possible; weaponisation unsubstantiated; deliberate age-targeted use strongly unsupported. Future inquiry should pursue missing primary data without politicising uncertainty, strengthen global biosafety and outbreak-reporting institutions, and resist converting demographic tragedy into proof of intent.
Andersen, K.G., Rambaut, A., Lipkin, W.I., Holmes, E.C. and Garry, R.F. (2020) ‘The proximal origin of SARS-CoV-2’, Nature Medicine, 26, pp. 450–452. doi: 10.1038/s41591-020-0820-9. Alwine, J.C. et al. (2023) ‘A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses’, Journal of Virology, 97. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10117112/ (Accessed: 19 August 2026). Bonanad, C. et al. (2020) ‘The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects’, Journal of the American Medical Directors Association, 21(7), pp. 915–918. doi: 10.1016/j.jamda.2020.05.045. Crits-Christoph, A. et al. (2024) ‘Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic’, Cell, 187. doi: 10.1016/j.cell.2024.08.010. Deng, Z. and colleagues (2024) ‘Achilles’ heel: elderly COVID-19 vaccination policy in China’, Vaccines. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11299290/ (Accessed: 19 August 2026). Fung, I.C.-H. et al. (2026) ‘Excess mortality in Mainland China after the end of the zero-COVID policy: a systematic review’, Epidemiology & Infection. Available at: https://www.cambridge.org/core/journals/epidemiology-and-infection/ (Accessed: 19 August 2026). Gong, D. et al. (2024) ‘Economic impacts of China’s zero-COVID policies’, Journal of Comparative Economics, 52. doi: 10.1016/j.jce.2023.11.004. International Monetary Fund (2022) World Economic Outlook: Countering the Cost-of-Living Crisis. Washington, DC: IMF. Available at: https://www.imf.org/en/Publications/WEO/Issues/2022/10/11/world-economic-outlook-october-2022 (Accessed: 19 August 2026). Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) ‘The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020’, China CDC Weekly, 2(8), pp. 113–122. doi: 10.46234/ccdcw2020.032.
Publication Date
8/21/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
1
Total views since publication
PDF Downloads
3
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...